FdaApplication
NDA 214517
Identifiers
- fda_app_no: NDA214517
Properties
| Property | Value |
|---|---|
| applicant_name | VANDA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2020-12-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HETLIOZ LQ | TASIMELTEON | 4MG/ML | SUSPENSION;ORAL |
| HETLIOZ LQ | TASIMELTEON | 4MG/ML | SUSPENSION;ORAL |
2 products